FdaApplication
ANDA 204502
Identifiers
- fda_app_no: ANDA204502
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2016-03-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | EQ 150MG BASE | TABLET;ORAL |
1 product